A Survey on the Role and Benefits of Online Social Networks on Filipino Patients With Psoriasis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01465061|
Recruitment Status : Completed
First Posted : November 4, 2011
Last Update Posted : November 4, 2011
|Condition or disease||Intervention/treatment|
|Psoriasis||Behavioral: Online support group|
|Study Type :||Observational|
|Actual Enrollment :||124 participants|
|Observational Model:||Ecologic or Community|
|Official Title:||A Survey on the Role and Benefits of Online Social Networks on Filipino Patients With Psoriasis|
|Study Start Date :||February 2011|
|Actual Primary Completion Date :||June 2011|
|Actual Study Completion Date :||August 2011|
|Online support user||
Behavioral: Online support group
Joining online support group
Other Name: Online social network, virtual online community
- Demographic profile of online support users [ Time Frame: 3 months ]The sociodemographic profile of the respondents such as age (mean, range), sex, civil status, level of formal education, employment status were described.
- Disease characteristics of online support users [ Time Frame: 3 months ]The overall health status (poor, average, good), psoriasis severity (mild, moderate, severe), duration of illness of online support groups were evaluated.
- Activities performed and extent of participation of online support users [ Time Frame: 3 months ]Participants were also asked regarding their attitudes and experiences with online communities, length of use, log-on frequency and nature of online activities.
- Empowering processes and outcomes experienced by online support group members [ Time Frame: 3 months ]The frequency with which empowering processes (exchange information, find recognition, share experiences, encounter emotional support, help others) occurred were measured on a 3-point scale (1-seldom to never, 2-sometimes, 3-often). The outcomes experienced (are better informed, feel more confident in relationship with physician, have improved acceptance, feel more confident with treatment, have enhanced social well-being, have increased optimism and control over the future, have enhanced self-esteem) were assessed on a 3-point scale (1-disagree, 2-neither agree nor disagree, 3-agree).
- Correlation of variables [ Time Frame: 3 months ]Intervariable correlation (overall health status/psoriasis severity with frequency/duration of usage, educational level/employment status with frequency of usage) were also be assessed for significance.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01465061
|Principal Investigator:||Charlene U Ang-Tiu, MD||University of the Philippines-Philippine General Hospital Section of Dermatology|